Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Durable Disease Control Possible After Stopping Immune Checkpoint Inhibitors in NSCLC

Prolonged disease control can be maintained for patients with advanced non-small cell lung cancer (NSCLC) who discontinue immune checkpoint inhibitors (ICIs) fo

Emergency Care Becoming Increasingly Vulnerable in the United States

The viability of hospital-based emergency care in the United States is at risk, according to a RAND report released April 7. Mahshid Abir, M.D., from RAND in Sa

Air, Light Pollution May Increase Risk for Pediatric Papillary Thyroid Cancer

Early-life exposure to fine particulate matter (PM2.5) and outdoor artificial light at night (O-ALAN) is associated with pediatric papillary thyroid cancer, acc

School-Based Asthma Programs Keep Kids Healthy And Learning

Kids struggle with asthma as much at school as they do at home possibly even more so, since it can be tough for them to access their medicine.So why aren t all

'The Talk' Is A Touchy Subject For Many Parents

TUESDAY, April 22, 2025 The Talk.It s an anxiety-producing proposition for just about every parent and as you might expect, opinions vary widely about when and

Most Women Are Comfortable With AI-Assisted Mammography

Women are OK with having an AI program help doctors review mammograms performed for breast cancer screening, a new study says.About 7 out of 10 women (71 ) said

Immune Therapy Works As Well In Senior Cancer Patients As In Younger Adults

TUESDAY, April 22, 2025 It s well-known that a person s immune system wears down over time, becoming less effective as folks progress through middle age and bec

RFK Jr.'s Major Autism Study To Use Private Health Records

TUESDAY, April 22, 2025 The National Institutes of Health (NIH) will provide private health data to researchers for U.S. health chief Robert F. Kennedy Jr. s ne

Click Therapeutics Announces FDA Marketing Authorization for CT-132, the First Prescription Digital Therapeutic for the Preventive Treatment of Episodic Migraine in the United States

NEW YORK, N.Y. (April 15, 2025) Click Therapeutics, Inc., ( Click ) a leader in prescription medical treatments as both prescription digital therapeutics and so

BlueRock Therapeutics Announces Publication in Nature of 18-Month Data from Phase 1 Clinical Trial for Bemdaneprocel, an Investigational Cell Therapy for Parkinson’s Disease

Cambridge MA, USA, April 16, 2025 BlueRock Therapeutics LP, a clinical-stage cell therapy company and wholly owned subsidiary of Bayer AG, today announced the p

Popular Keywords